Datametrex AI Ltd V.DM

At least Marshall is still CEO

[Aiking]

A few weeks ago Marshall Gunter LinkedIn profile was down. Now it is back again! He is still there and as we had no huge selling before the sp collapse - and I assume all the people at DM who know how it is in real, are still on board and hopefully they are the buyers right now.
But yes, don't get me wrong, I would really like to see us up again and as I said, if DM is able to bring up a sales strategy I still believe they can catch up the Ai trend and make this company a succesfull Ai company.

[rollthedice10]

I agree 100%. I think it would be a mistake to count DM out of the game. I have seen beat up Companies rise from far worse than this. I just wish I was buying now instead of all those more expensive shares I have been accumulating like a squirrel before Winter. I guess that idea was nuts.

[Aiking]

Hey @rollthedice: It seems like you and me are the only optimists right now. Alle the other believers seem to be gone.

[Bentley2000]

Bentley still here...I" m a believer!!!

[Forge24]

Hard to be optimistic when we haven't even seen any demos for AGPT yet or the individual user price plan which should've been released weeks ago per MG. Clinics are the only glimmer of hope right now amongst an ocean of bad news and uncertainty. 

[rollthedice10]

It appears that way. But after taking a hoof to the groin, many may lose their optimism. I still think this can and will fly. But I have been around the block quite a few times and know sh*t happens and I might just have to suffer a beat down once in a while. I'm as angry and frustrated as anyone else. Sometimes ya gotta go through hell before you get to heaven. Excessive pumping or bashing at

[BamBamMarket]

This post has been removed in accordance with Community Policy

[RazeKreations]

Still here

[Aiking]

Hey @Raze, nice you're here too. What do you think about DM future?

[RazeKreations]

The health care side of things are progressing forward and providing some income and should continue to grow. Nexalagy has been tested and was able to move forward with the government testing programs. AGPT appears to be the biggest opportunity for substantial growth but the strategy to bring it to market needs different direction. Maybe this current downturn will give them the kick in the pants